These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10931192)

  • 1. Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity.
    Dobers J; Grams S; Reutter W; Fan H
    Eur J Biochem; 2000 Aug; 267(16):5093-100. PubMed ID: 10931192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
    Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
    Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-specific N-glycosylation of the membrane glycoprotein dipeptidylpeptidase IV (CD26) influences its subcellular trafficking, biological stability, enzyme activity and protein folding.
    Fan H; Meng W; Kilian C; Grams S; Reutter W
    Eur J Biochem; 1997 May; 246(1):243-51. PubMed ID: 9210490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells.
    Dobers J; Zimmermann-Kordmann M; Leddermann M; Schewe T; Reutter W; Fan H
    Protein Expr Purif; 2002 Aug; 25(3):527-32. PubMed ID: 12182835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
    Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
    Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
    Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
    Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
    Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
    Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
    J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of enzymatically active rat dipeptidyl peptidase IV in Chinese hamster ovary cells after transfection.
    Hong WJ; Piazza GA; Hixson DC; Doyle D
    Biochemistry; 1989 Oct; 28(21):8474-9. PubMed ID: 2605197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum.
    Tsuji E; Misumi Y; Fujiwara T; Takami N; Ogata S; Ikehara Y
    Biochemistry; 1992 Dec; 31(47):11921-7. PubMed ID: 1359907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
    Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
    J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid inhibition of dipeptidyl peptidase IV in vitro is dependent on the intracellular formation of triuret.
    Mohandas R; Sautina L; Beem E; Schuler A; Chan WY; Domsic J; McKenna R; Johnson RJ; Segal MS
    Exp Cell Res; 2014 Aug; 326(1):136-42. PubMed ID: 24925478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPPIV/CD26: a tumor suppressor or a marker of malignancy?
    Beckenkamp A; Davies S; Willig JB; Buffon A
    Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
    Cao W; Matherly LH
    Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
    Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
    Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
    Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
    J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.